PubMed=8978593; DOI=10.1159/000227661
Yasunori Wakahara, Akihiro Nawa, Tomomitsu Okamoto, Akemi Hayakawa, Fumitaka Kikkawa, Nobuhiko Suganama, Fumiyo Wakahara, Yutaka Tomoda;
Combination effect of anti-Fas antibody and chemotherapeutic drugs in ovarian cancer cells in vitro.
Oncology 54:48-54(1997)

PubMed=9344045; DOI=10.1023/A:1018495414975
Kiyosumi Shibata, Fumitaka Kikkawa, Akihiro Nawa, Koji Tamakoshi, Nobuhiko Suganuma, Yutaka Tomoda;
Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.
Clin. Exp. Metastasis 15:612-619(1997)

PubMed=10403549; DOI=10.1016/S0304-3835(99)00062-2
Akemi Hayakawa, Itsuo Yokoyama, Hisao Tajiri, Tomomitsu Okamoto, Izumi Nakashima;
Protein kinase C-dependent anti-apoptotic mechanism that is associated with high sensitivity to anti-Fas antibody in ovarian cancer cell lines.
Cancer Lett. 140:113-119(1999)

PubMed=11865194; DOI=10.1023/A:1014302212321
Akemi Hayakawa, Jiang-Hong Wu, Yoshiyuki Kawamoto, Yan-Wen Zhou, Sei-ichi Tanuma, Izumi Nakashima, Haruhiko Suzuki;
Activation of caspase-8 is critical for sensitivity to cytotoxic anti-Fas antibody-induced apoptosis in human ovarian cancer cells.
Apoptosis 7:107-113(2002)

PubMed=12767062; DOI=10.1002/ijc.11177
Fumitaka Kikkawa, Hiroaki Kajiyama, Kazuhiko Ino, Kiyosumi Shibata, Shigehiko Mizutani;
Increased adhesion potency of ovarian carcinoma cells to mesothelial cells by overexpression of dipeptidyl peptidase IV.
Int. J. Cancer 105:779-783(2003)